1021 related articles for article (PubMed ID: 27884168)
21. A novel pathogenic variant in an Iranian Ataxia telangiectasia family revealed by next-generation sequencing followed by in silico analysis.
Tabatabaiefar MA; Alipour P; Pourahmadiyan A; Fattahi N; Shariati L; Golchin N; Mohammadi-Asl J
J Neurol Sci; 2017 Aug; 379():212-216. PubMed ID: 28716242
[TBL] [Abstract][Full Text] [Related]
22. Oxidative stress in ataxia telangiectasia.
Watters DJ
Redox Rep; 2003; 8(1):23-9. PubMed ID: 12631440
[TBL] [Abstract][Full Text] [Related]
23. Absence of mutations in ATM, the gene responsible for ataxia telangiectasia in patients with cerebellar ataxia.
Hassin-Baer S; Bar-Shira A; Gilad S; Galanty Y; Khosravi R; Lossos A; Giladi N; Weitz R; Ben-Zeev B; Goldhammer Y; Shiloh Y
J Neurol; 1999 Aug; 246(8):716-9. PubMed ID: 10460451
[TBL] [Abstract][Full Text] [Related]
24. Ataxia-telangiectasia in the south of Tunisia: A study of 11 cases.
Sfaihi L; Stoppa Lyonnet D; Ben Ameur S; Dubois D'enghien C; Kamoun T; Barbouch MR; Hachicha M
Tunis Med; 2015; 93(8-9):511-5. PubMed ID: 26815515
[TBL] [Abstract][Full Text] [Related]
25. Childhood-Onset Movement Disorders Can Mask a Primary Immunodeficiency: 6 Cases of Classical Ataxia-Telangiectasia and Variant Forms.
Blanchard-Rohner G; Peirolo A; Coulon L; Korff C; Horvath J; Burkhard PR; Gumy-Pause F; Ranza E; Jandus P; Dibra H; Taylor AMR; Fluss J
Front Immunol; 2022; 13():791522. PubMed ID: 35154108
[TBL] [Abstract][Full Text] [Related]
26. Ataxia Telangiectasia Diagnosed on Newborn Screening-Case Cohort of 5 Years' Experience.
Mandola AB; Reid B; Sirror R; Brager R; Dent P; Chakroborty P; Bulman DE; Roifman CM
Front Immunol; 2019; 10():2940. PubMed ID: 31921190
[TBL] [Abstract][Full Text] [Related]
27. Molecular pathology of ataxia telangiectasia.
Taylor AM; Byrd PJ
J Clin Pathol; 2005 Oct; 58(10):1009-15. PubMed ID: 16189143
[TBL] [Abstract][Full Text] [Related]
28. [Ataxia telangiectasia syndrome: clinical picture and immunological abnormalities].
Pietrucha B; Kmieć T; Mikołuć B; Bernatowska E; Jastrzebska-Piotrowska J; Pac M; Wolska-Kuśnierz B; Kuczyński D
Neurol Neurochir Pol; 2004; 38(1 Suppl 1):S1-7. PubMed ID: 15045861
[TBL] [Abstract][Full Text] [Related]
29. Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia.
Lavin MF; Gueven N; Bottle S; Gatti RA
Br Med Bull; 2007; 81-82():129-47. PubMed ID: 17586848
[TBL] [Abstract][Full Text] [Related]
30. Clinical spectrum of ataxia-telangiectasia in adulthood.
Verhagen MM; Abdo WF; Willemsen MA; Hogervorst FB; Smeets DF; Hiel JA; Brunt ER; van Rijn MA; Majoor Krakauer D; Oldenburg RA; Broeks A; Last JI; van't Veer LJ; Tijssen MA; Dubois AM; Kremer HP; Weemaes CM; Taylor AM; van Deuren M
Neurology; 2009 Aug; 73(6):430-7. PubMed ID: 19535770
[TBL] [Abstract][Full Text] [Related]
31. Presence of ATM protein and residual kinase activity correlates with the phenotype in ataxia-telangiectasia: a genotype-phenotype study.
Verhagen MM; Last JI; Hogervorst FB; Smeets DF; Roeleveld N; Verheijen F; Catsman-Berrevoets CE; Wulffraat NM; Cobben JM; Hiel J; Brunt ER; Peeters EA; Gómez Garcia EB; van der Knaap MS; Lincke CR; Laan LA; Tijssen MA; van Rijn MA; Majoor-Krakauer D; Visser M; van 't Veer LJ; Kleijer WJ; van de Warrenburg BP; Warris A; de Groot IJ; de Groot R; Broeks A; Preijers F; Kremer BH; Weemaes CM; Taylor MA; van Deuren M; Willemsen MA
Hum Mutat; 2012 Mar; 33(3):561-71. PubMed ID: 22213089
[TBL] [Abstract][Full Text] [Related]
32. [Pathogenesis, diagnosis, clinical and therapeutic aspects of ataxia telangiectasia].
Güngör T; Bühring I; Cremer R; Gartenschläger M; Zielen S
Klin Padiatr; 1997; 209(5):328-35. PubMed ID: 9411043
[TBL] [Abstract][Full Text] [Related]
33. Rapid molecular diagnosis of ataxia-telangiectasia by optimised RT-PCR and direct sequencing analysis.
Mancebo E; Pacho A; de Pablos P; Muñoz-Robles J; Castro MJ; Romo E; Morales P; González L; Paz-Artal E; Allende LM
Immunobiology; 2005; 210(5):279-82. PubMed ID: 16164035
[TBL] [Abstract][Full Text] [Related]
34. [Clinical, biological and genetic study of 24 patients with ataxia telangiectasia from southern Tunisia].
Triki C; Feki I; Meziou M; Turki H; Zahaf A; Mhiri C
Rev Neurol (Paris); 2000 Jul; 156(6-7):634-7. PubMed ID: 10891797
[TBL] [Abstract][Full Text] [Related]
35. Refractory T-cell/histiocyte-rich large B-cell lymphoma in a patient with ataxia-telangiectasia caused by novel compound heterozygous variants in ATM.
Sato D; Moriya K; Nakano T; Miyagawa C; Katayama S; Niizuma H; Sasahara Y; Kure S
Int J Hematol; 2021 Dec; 114(6):735-741. PubMed ID: 34424493
[TBL] [Abstract][Full Text] [Related]
36. Do elevated serum IgM levels have to be included in probable diagnosis criteria of patients with ataxia-telangiectasia?
Azarsiz E; Karaca NE; Gunaydin NC; Gulez N; Ozturk C; Aksu G; Genel F; Kutukculer N
Int J Immunopathol Pharmacol; 2014; 27(3):421-7. PubMed ID: 25280033
[TBL] [Abstract][Full Text] [Related]
37. Clinical diagnosis and genetic counseling of atypical ataxia‑telangiectasia in a Chinese family.
Cao J; Shen R; Zhang W; Mao B; Shi Q; Zhou R; Liu Z; Zeng B; Chen X; Zhang C; Lu M; Han P; Wu J; Zhou A; Tan X
Mol Med Rep; 2019 May; 19(5):3441-3448. PubMed ID: 30816533
[TBL] [Abstract][Full Text] [Related]
38. Alteration in 5-hydroxymethylcytosine-mediated epigenetic regulation leads to Purkinje cell vulnerability in ATM deficiency.
Jiang D; Zhang Y; Hart RP; Chen J; Herrup K; Li J
Brain; 2015 Dec; 138(Pt 12):3520-36. PubMed ID: 26510954
[TBL] [Abstract][Full Text] [Related]
39. Atm expression patterns suggest a contribution from the peripheral nervous system to the phenotype of ataxia-telangiectasia.
Soares HD; Morgan JI; McKinnon PJ
Neuroscience; 1998 Oct; 86(4):1045-54. PubMed ID: 9697112
[TBL] [Abstract][Full Text] [Related]
40. Role of DDX1 in the oxidative response of ataxia telangiectasia patient-derived fibroblasts.
Garg M; Li L; Godbout R
Redox Biol; 2024 Feb; 69():102988. PubMed ID: 38096740
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
